Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2022-09-27 00:00:00 ET · period of report 2022-09-26 · accession 0001209191-22-051391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-27 | 2022-09-26 | WHWK | Castelein Caley | Dir | A - Grant | $12.50 | +240.0K | 500.0K | +92% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-26 | A | A | 240,000 | $12.50 | 499,998 | I See footnote | — | — | (F1) Shares held by KVP Capital, LP. The Reporting Person is the Managing Director of KVP Capital. The Reporting Person disclaims beneficial ownership of shares held by KVP Capital, except to the extent of their pecuniary interest therein. |